South Korea · Delayed Price · Currency is KRW Kookjeon Pharmaceutical Statistics
Total Valuation
KOSDAQ:307750 has a market cap or net worth of KRW 120.66 billion. The enterprise value is 131.70 billion.
| Market Cap | 120.66B |
| Enterprise Value | 131.70B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:307750 has 53.99 million shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 53.99M |
| Shares Outstanding | 53.99M |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 52.20% |
| Owned by Institutions (%) | 0.16% |
| Float | 25.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.95 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | 26.65 |
| P/OCF Ratio | 14.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.23, with an EV/FCF ratio of 29.09.
| EV / Earnings | n/a |
| EV / Sales | 1.03 |
| EV / EBITDA | 25.23 |
| EV / EBIT | n/a |
| EV / FCF | 29.09 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.37.
| Current Ratio | 1.32 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 7.68 |
| Debt / FCF | 8.88 |
| Interest Coverage | -0.00 |
Financial Efficiency
Return on equity (ROE) is -7.91% and return on invested capital (ROIC) is -0.01%.
| Return on Equity (ROE) | -7.91% |
| Return on Assets (ROA) | -0.00% |
| Return on Invested Capital (ROIC) | -0.01% |
| Return on Capital Employed (ROCE) | -0.01% |
| Weighted Average Cost of Capital (WACC) | 2.48% |
| Revenue Per Employee | 715.88M |
| Profits Per Employee | -44.10M |
| Employee Count | 178 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.40 |
Taxes
| Income Tax | -1.24B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.61% in the last 52 weeks. The beta is -0.74, so KOSDAQ:307750's price volatility has been lower than the market average.
| Beta (5Y) | -0.74 |
| 52-Week Price Change | -44.61% |
| 50-Day Moving Average | 3,090.54 |
| 200-Day Moving Average | 3,551.11 |
| Relative Strength Index (RSI) | 38.40 |
| Average Volume (20 Days) | 204,454 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:307750 had revenue of KRW 127.43 billion and -7.85 billion in losses. Loss per share was -156.21.
| Revenue | 127.43B |
| Gross Profit | 19.44B |
| Operating Income | -14.25M |
| Pretax Income | -9.49B |
| Net Income | -7.85B |
| EBITDA | 5.24B |
| EBIT | -14.25M |
| Loss Per Share | -156.21 |
Balance Sheet
The company has 30.39 billion in cash and 40.19 billion in debt, with a net cash position of -9.80 billion or -181.59 per share.
| Cash & Cash Equivalents | 30.39B |
| Total Debt | 40.19B |
| Net Cash | -9.80B |
| Net Cash Per Share | -181.59 |
| Equity (Book Value) | 107.87B |
| Book Value Per Share | 1,975.28 |
| Working Capital | 20.18B |
Cash Flow
In the last 12 months, operating cash flow was 8.45 billion and capital expenditures -3.92 billion, giving a free cash flow of 4.53 billion.
| Operating Cash Flow | 8.45B |
| Capital Expenditures | -3.92B |
| Depreciation & Amortization | 5.25B |
| Net Borrowing | -14.07B |
| Free Cash Flow | 4.53B |
| FCF Per Share | 83.85 |
Margins
Gross margin is 15.25%, with operating and profit margins of -0.01% and -6.16%.
| Gross Margin | 15.25% |
| Operating Margin | -0.01% |
| Pretax Margin | -7.45% |
| Profit Margin | -6.16% |
| EBITDA Margin | 4.11% |
| EBIT Margin | -0.01% |
| FCF Margin | 3.55% |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 0.51%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 0.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.15% |
| Shareholder Yield | -0.64% |
| Earnings Yield | -6.51% |
| FCF Yield | 3.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:307750 has an Altman Z-Score of 2.34 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | 6 |